🚧 Under construction — Data may be inaccurate. We are actively adding more companies and metrics.

Synopsys, Inc. vs Regeneron Pharmaceuticals, Inc.

Market cap comparison over time

Synopsys, Inc.

$78.7B

Rank #205

Regeneron Pharmaceuticals, Inc.

$80.6B

Rank #200

Market Cap Over Time

Key Moments

  • Regeneron Pharmaceuticals, Inc. overtook Synopsys, Inc. by 2011
  • Synopsys, Inc. overtook Regeneron Pharmaceuticals, Inc. by 2020
  • Regeneron Pharmaceuticals, Inc. overtook Synopsys, Inc. by 2022
  • Synopsys, Inc. overtook Regeneron Pharmaceuticals, Inc. by 2023
  • Regeneron Pharmaceuticals, Inc. overtook Synopsys, Inc. by 2026

Year-by-Year Comparison

YearSynopsys, Inc.Regeneron Pharmaceuticals, Inc.Leader
2026$78.7B$80.6BRegeneron Pharmaceuticals, Inc.
2025$89.9B$79.3BSynopsys, Inc.
2024$92.9B$72.8BSynopsys, Inc.
2023$98.6B$89.7BSynopsys, Inc.
2022$61.1B$73.7BRegeneron Pharmaceuticals, Inc.
2021$70.6B$64.5BSynopsys, Inc.
2020$49.6B$49.4BSynopsys, Inc.
2019$26.7B$38.4BRegeneron Pharmaceuticals, Inc.
2018$16.1B$38.2BRegeneron Pharmaceuticals, Inc.
2017$16.3B$38.4BRegeneron Pharmaceuticals, Inc.
2016$11.3B$37.5BRegeneron Pharmaceuticals, Inc.
2015$8.7B$55.5BRegeneron Pharmaceuticals, Inc.
2014$8.3B$41.9BRegeneron Pharmaceuticals, Inc.
2013$7.8B$28.1BRegeneron Pharmaceuticals, Inc.
2012$6.1B$17.5BRegeneron Pharmaceuticals, Inc.
2011$5.2B$5.7BRegeneron Pharmaceuticals, Inc.
2010$5.2B$3.4BSynopsys, Inc.
2009$4.3B$2.5BSynopsys, Inc.
2008$3.5B$1.9BSynopsys, Inc.
2007$5.0B$2.5BSynopsys, Inc.
2006$5.1B$2.1BSynopsys, Inc.
2005$3.8B$1.6BSynopsys, Inc.
2004$3.7B$941.1MSynopsys, Inc.
2003$6.5B$1.5BSynopsys, Inc.
2002$4.4B$1.9BSynopsys, Inc.
2001$5.7B$2.9BSynopsys, Inc.
2000$4.5B$3.6BSynopsys, Inc.
1999$6.4B$1.3BSynopsys, Inc.
1998$5.2B$753.6MSynopsys, Inc.
1997$3.4B$874.9MSynopsys, Inc.
1996$4.4B$1.6BSynopsys, Inc.
1995$3.6B$1.3BSynopsys, Inc.
1994$2.1B$306.5MSynopsys, Inc.